BioNTech SE Sponsored ADR
(NASDAQ: BNTX)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

91.190 -

+1.090 (+1.21%)
Range 89.600 - 91.600   (2.23%)
Open 90.060
Previous Close 90.100
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 1,407,398
Value 98,487,903
Remark -
Delayed prices. Updated at 14 Mar 2026 08:15.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis